Skip to main content
SpringerLink
Log in

Clinicopathologic Features and Risk Factors for Extrahepatic Recurrences of Hepatocellular Carcinoma After Curative Resection

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients with extrahepatic metastasis after the removal of primary HCC, and the risk factors of extrahepatic recurrence.

Methods

Clinicopathologic data were available for 264 HCC patients who underwent an R0 resection for HCC. Twenty-six patients who developed extrahepatic recurrence during the follow-up period (EXT group) were compared with patients who remained free from recurrence for at least 5 years after resection (n = 46) (No R group) or had only intrahepatic recurrences (n = 193) (INT group). We also estimated the risk factors of extrahepatic recurrence and survival in these 26 patients.

Results

There were significant differences in primary tumor size, patient’s age, findings in the noncancerous portion, macroscopic type, ductal invasion, intrahepatic metastasis, hepatic involvement and curability of primary tumor, treatment for recurrent tumor, and prognosis between the EXT group and the other groups. Extrahepatic recurrence was significantly associated with six factors by univariate analyses: age, indocyanine green (ICG) 15-min retention rate, tumor size, hepatic involvement of primary tumor, type of hepatectomy, and TNM stage, of which tumor size was an independent risk factor. Resection of recurrent tumor was the only independent favorable factor for survival of patients with extrahepatic recurrence.

Conclusions

HCC patients with extrahepatic recurrence had advanced primary tumors and poor prognosis. HCC patients with primary tumors larger than 60 mm were predicted to develop extrahepatic recurrence. Resection of recurrent tumor can improve the prognosis of HCC patients with extrahepatic recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117

    Article  PubMed  CAS  Google Scholar 

  2. Balsells J, Charco R, Lazaro JL et al (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761

    Article  PubMed  CAS  Google Scholar 

  3. Chan KM, Yu MC, Wu TJ et al (2009) Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 15:5481–5488

    Article  PubMed  Google Scholar 

  4. Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746

    Article  PubMed  Google Scholar 

  5. Yuki K, Hirohashi S, Sakamoto M et al (1990) Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66:2174–2179

    Article  PubMed  CAS  Google Scholar 

  6. Belghiti J, Regimbeau JM, Durand F et al (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41–46

    PubMed  CAS  Google Scholar 

  7. Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802

    Article  PubMed  Google Scholar 

  8. Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350

    PubMed  CAS  Google Scholar 

  9. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304

    Article  PubMed  CAS  Google Scholar 

  10. Liver Cancer Study Group of Japan (2003) General rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo, pp 13–28

    Google Scholar 

  11. Sobin LH, Wittekind CH (eds) (1997) TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 81–83

    Google Scholar 

  12. Kokudo N, Makuuchi M (2009) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 44(Suppl 19):119–121

    Article  PubMed  Google Scholar 

  13. Arii S, Sata M, Sakamoto M et al (2010) Management of hepatocellular carcinoma: report of consensus meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 40:667–685

    Article  PubMed  Google Scholar 

  14. Wang J, Xu LB, Liu C, Pang HW, Chen YJ, Ou QJ (2010) Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center. World J Surg 34:2434–2441. doi:10.1007/s00268-010-0664-4

    Article  PubMed  Google Scholar 

  15. Sonoyama T, Ochiai T, Hironaka T et al (2003) Predictors of postoperative diffuse recurrence of hepatocellular carcinoma. Hepatogastroenterology 50:1078–1084

    PubMed  Google Scholar 

  16. Tanaka K, Shimada H, Matsuo K et al (2008) Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg 32:1738–1747. doi:10.1007/s00268-008-9613-x

    Article  PubMed  Google Scholar 

  17. Sasaki A, Kai S, Endo Y et al (2007) Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Ann Surg Oncol 14:3181–3187

    Article  PubMed  Google Scholar 

  18. Ogawa M, Yamamoto T, Kudo S et al (2004) Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 29:228–234

    Article  PubMed  Google Scholar 

  19. Liu Y, Wu MC, Qian GX et al (2002) Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction. Hepatobiliary Pancreat Dis Int 1:72–76

    PubMed  Google Scholar 

  20. Hasegawa K, Takayama T, Ijichi M et al (2006) Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 44:865–891

    Article  Google Scholar 

  21. Takayama T, Sekine T, Makuuchi M et al (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802–807

    Article  PubMed  CAS  Google Scholar 

  22. Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801

    Article  PubMed  Google Scholar 

  23. Poon RT, Fan ST, O’Suilleabhain CB et al (2002) Aggressive management of patients with extrahepatic and intrahepatic recurrence of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 195:311–318

    Article  PubMed  Google Scholar 

  24. Aramaki M, Kawano K, Kai T et al (1999) Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection. Hepatogastroenterology 46:2931–2934

    PubMed  CAS  Google Scholar 

  25. Jang JW, Kay CS, You CR et al (2009) Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 74:412–418

    Article  PubMed  Google Scholar 

  26. Hawkins MA, Dawson LA (2006) Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106:1653–1663

    Article  PubMed  Google Scholar 

  27. Katamura Y, Aikata H, Kimura Y et al (2010) Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases. J Gastroenterol Hepatol 25:1117–1122

    Article  PubMed  CAS  Google Scholar 

  28. Hsu CH, Yang TS, Hsu C et al (2010) Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy inpatients with advanced hepatocellular carcinoma. Br J Cancer 102:981–986

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-Kawaramachi, Kamigyo-ku, Kyoto, 602-8566, Japan

    Toshiya Ochiai, Hisashi Ikoma, Kazuma Okamoto, Yukihito Kokuba, Teruhisa Sonoyama & Eigo Otsuji

Authors
  1. Toshiya Ochiai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisashi Ikoma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuma Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yukihito Kokuba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teruhisa Sonoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eigo Otsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiya Ochiai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ochiai, T., Ikoma, H., Okamoto, K. et al. Clinicopathologic Features and Risk Factors for Extrahepatic Recurrences of Hepatocellular Carcinoma After Curative Resection. World J Surg 36, 136–143 (2012). https://doi.org/10.1007/s00268-011-1317-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1317-y

Keywords

Search

Navigation